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Abstract 
 Today most of the non-communicable diseases have higher prevalence. Sthaulya (obesity or over-
weight) is one of them. This disorder has constituted a most important epidemic in the initial decades of 
the 21st century. Taking into consideration this fact a randomized clinical study was carried out with an 
aim to study the clinical efficacy of “Bilvadi Panchmool Ghanvati” in the management of Sthaulya 
(obesity). Amongst these, 15 patients were treated with Bilvadi Panchmool Ghanvati compound in the 
dose of 2 gram (4 tablets of 500 mg) 3 times a day with Madhudak before meal. The duration of treatment 
was 8 weeks with follow‑up for 4 weeks after the completion of treatment. Analysis of the overall effects 
showed that Bilvadi Panchmool Ghanvati provided marked reduction in weight, body mass index, and 
other signs and symptoms in patients of Sthaulya . 
Keywords: Sthaulya, obesity, Bilvadi Panchmool Ghanvati. 
*Corresponding Author: 
Vyas Jatin M  
Lecturer,  
Department of Kayachikitsa,  
J.S.Ayurved College,  
Nadiad  
E-mail: vaidyajatinvyas87@gmail.com  
Introduction 
Sthaulya is metabolic disorder described in 
Ayurvedic texts thousands of years ago. The same 
etiopathogenesis and symptomatology present today as 
described in classics. Acharya Sushruta said that the last 
complication of Sthaulya is Panchapanchatva which 
means death. W.H.O. has undertaken obesity in 10 
selected risks to the health in “The World Health Report 
- 2002”.  
Obesity is a chronic disease that is highly 
prevalent and that poses a serious risk for the 
development of diabetes mellitus, hypertension, 
cardiovascular diseases, musculoskeletal disorders 
especially osteoarthritis and certain forms of cancer.(1), 
(2). 
Obesity has taken place as an epidemic problem 
yet still majority of people are not aware of the factors 
that welcome this problem and the results that are 
obtained after one gets into this problem. At least 2.6 
million people each year die as a result of being 
overweight or obese.(3). 
Sthaulya is considered as Santarpanjanya Vyadhi 
(over nutritional) (4), due to excessive accumulation of 
Meda (depot fat) in Body. Because of Dietary habits, 
sedentary life style, stress, technology etc. it has 
become widespread disease with so many complaints. If 
we go through Ayurvedic formulations which are used 
in Sthaulya, Guggulu is found to be main ingredient in 
most of them. But it is also seen that Guggulu is not 
suitable to all in context to Prakriti, Desha and Kala etc. 
So there is necessity to find out substitute. 
While describing the treatment of Sthaulya, 
Acharya Charaka emphasized on the use of Ruksha, 
Ushna and mainly Kapha Vatashamana drugs like 
Bilvadi Panchmool and use of Madhu Udaka for the 
management of Sthaulya. (5) Therefore Bilvadi 
Panchmool Ghanvati was selected for clinical study. 
In Bilvadi Panchmool Ghanvati, there is 
combination of five drugs i.e. Bilva, Agnimanth, 
Gambhari, Patla and Shyonak. 
 
Aims and Objectives 
 To study causes of Sthaulya described in classics. 
 To study the clinical efficacy of “Bilvadi Panchmool 
Ghanvati” in the management of Sthaulya (obesity).
   
Materials and Methods  
 A total of 17 patients of Sthaulya from O.P.D. 
and I.P.D. of Govt. Akhandanand Ayurvedik Hospital, 
as well as Govt. Maniben Ayurvedik Hospital, 
Ahmedabad were registered for this study. Out of this 2 
Patients dropped out, and 15 patients completed the 
prescribed course of treatment. 
 
Plan of Study 
 An open label clinical trial was conducted on 
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patients, where patients were given treatment for 8 
weeks with 4 months follow up. Patients were given 
specific instructions on diet and life style modifications. 
Bilvadi Panchmool Ghanvati given in 4 tablets (each 
tablet 500mg) thrice a day with Madhudaka. The 
composition of Bilvadi Panchmool Ghanvati is 
described below.  
 
 
Inclusion criteria 
 Patient having classical sign and symptoms of 
Sthaulya like Chala Sphika Udara, Stana, Durbalya, 
Atikshudha, Atitrishna, Daurgandhya, Alpavyavaya 
etc. 
 Age: - 16-60 years. 
 BMI :- >25 and ≤40. 
 
Exclusion criteria 
 Patients having age < 16 years and > 60 years. 
 Patients having serious cardiac, pulmonary, renal 
and hepatic diseases etc.  
 Pregnant females and lactating women. 
 Patients having history of Diabetes Mellitus, Thyroid 
disorders and uncontrolled Hypertension and other 
endocrine diseases. 
 Obesity due to drugs e.g. Anticonvulsant, Beta-
blockers, Corticosteroid. 
 Patients having BMI > 40 were excluded. 
 
Investigation 
 S. Cholesterol and fasting blood sugar was carried 
out in all the patients before initiating the 
administration of trial drugs and after the completion 
of course of treatment. Routine investigation of 
blood and urine were also done to rule out other 
pathologies and to judge any adverse effect of the 
drugs. 
 
Criteria for assessment 
 Total Assessment of the Therapy was done on the 
basis of relief in the signs and symptoms as well as 
objective criteria Body weight measurement, BMI, 
W/H ratio, Skin fold thickness. The efficacy of the 
therapy was assessed on the basis of the following 
subjective as well as objective criteria. 
 
Subjective criteria 
 The patients were assessed twice by giving a 
score before and after the therapy according to the 
Content Latin name Part 
used 
Ratio 
Bilva Aegle marmelos 
corr. 
Root 1 part 
Agnimantha Premna  
mucronata roxb. 
Root 1 part 
Shyonaka Oroxylum indicum 
vent. 
Root 1 part 
Patla Stereospermum 
suaveolens dc. 
Root 1 part 
Gambhari Gmelina arborea 
linn. 
Root 1 part 
severity of the symptoms. Statistical analysis was 
carried out to obtain the efficacy of the therapy. 
 The details of the scoring pattern adopted for the 
main signs and symptoms in the present study were as 
follows.  
 
Chala Sphika Udara Stana (Visible Movement In Hip-
Abdomen-Breast) 
 
 
Alasya/ Utsahahani (Laziness/ Lack of Enthusiasm) 
 
 
Kshudra Shwasa/Ayase Shwasa (Dyspnoea On 
Exertion) 
 
 
 
Daurbalyata-Alpa Vyayama (Weakness) 
 
  
 
Absence of Chalatva 0 
Little visible movement (in the areas) after rap- 1 
Little visible movement (in the areas) even after 2 
Movement (in the areas) after mild movement 3 
Movement (in the areas) even after changing 4 
No Alasya or Lack of Enthusiasm (doing work 0 
Doing work satisfactorily with late initiation 1 
Doing work unsatisfactorily under mental pres- 2 
Not starting any work on his own responsibility 3 
Does not take any initiation and does not want 4 
No Dyspnoea even after heavy work 0 
Dyspnoea after moderate work but relieved lat-
er and tolerable; dyspnoea By climbing upstairs 
of 10 steps and time taken will be more than 15 
sec. 
1 
Dyspnoea after little work but relieved later and 
tolerable; dyspnoea by climbing upstairs of 10 
steps and time taken will be more than 25 sec. 
2 
Dyspnoea after little work but relieved later and 
not tolerable; dyspnoea 
by climbing upstairs of 10 steps and time taken 
will be more than 35 sec. 
3 
Dyspnoea in resting condition 4 
Can do routine exercise 0 
Can do moderate exercise without difficulty 1 
Can do only mild exercise 2 
Can do mild exercise with difficulty 3 
Cannot do even mild exercise 4 
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Nidradhikya (Excess sleep) 
 
  
Swedadhikya (Excess Sweating) 
 
  
Daurgandhya (Body Odour) 
 
 
Atipipasa (Excess Thirst) 
 
 
Atikshudha (Excess Hunger) 
 
   
Alpa Vyavaya (Less Libido) 
 
Normal and sound sleep for 6 – 8 hrs./24 hrs. 
with 
feeling of lightness and relaxation in the body 
and mind 
0 
Sleep ≥8 -9 hrs./24 hrs. With slight heaviness in 
the body. 
1 
Sleep >8 -9 hrs./24 hrs. With slight heaviness in 
the body. 
2 
Sleep >10 hrs./24 hrs. With heaviness in the 
body associated with Jrimbha and Tandra. 
3 
Sweating after heavy work and fast movement 
or in very hot weather. 
0 
Profuse sweating after moderate work and 
movement. 
1 
Sweating after little work and movement. 2 
Profuse sweating after little work and move-
ment. 
3 
Sweating even at rest or in cold season. 4 
No odour. 0 
Bad odour but not offensive. 1 
Strong odour but can be lessened by use of deo-
dorants or perfumes. 
2 
Very strong odour even after using fragrances 
(use of deodorants or perfumes). 
3 
Feeling of thirst (7 – 9 times/24 hours) and re-
lieved by drinking water. 
0 
Feeling of moderate thirst (>9 - 11 times/24 
hours) and relieved by drinking water. 
1 
Feeling of excess thirst (>11 – 13 times/24 
hours) not relieved by drinking water. 
2 
Feeling of sever thirst (>13 times/24 hours) not 
relieved by drinking water. 
3 
As usual / routine 0 
Slightly increased (1 meal extra with routine 
diet). 
1 
Moderately increased (2 meals extra with rou-
tine diet). 
2 
Markedly increased (3 meals extra with routine 
diet). 
3 
Unimpaired libido and sexual performance. 0 
Decrease in libido but can perform sexual act. 1 
Decrease in libido but can perform sexual act 
with difficulty. 
2 
Loss of libido and cannot perform sexual act. 3 
 Anga Shaithilya (Flabbiness in the body) 
 
 
Gadgadvani ( Indistinct speech)  
 
 
Associated Symptoms 
Sandhi Shool (Joint pain)  
 
 
The assessment was done before starting the 
treatment and after the treatment i.e.; at the completion 
of the treatment and the improvement was assessed on 
the basis of percentage relief obtained and statistical 
evaluations. 
 
Objective Criteria: 
Weight: Reduction of weight was compared in 
comparison before treatment and after treatment. 
 
Body mass index (BMI): 
 The body mass index (BMI) is a statistical 
measurement which compares a person's weight and 
height. The frequent use of the BMI is to assess how 
much an individual's body weight departs from what is 
normal or desirable for a person of his or her height. For 
a given height, BMI is proportional to weight. However, 
for a given weight, BMI is inversely proportional to the 
square of the height. The B.M.I. is the actual body 
weight divided by the height squared in meter (kg/m2). 
This index provides a satisfactory measure of obesity in 
people who are not hypertrophied athletes. The 
classification of obesity as per B.M.I. by W.H.O. 
Criteria is as: 
 Under weight - <18.5 kg/m2 
 Normal weight  - 18.5 - 24.9 kg/m2 
 Over weight   - 25 - 29.9 kg/m2 
 Obesity (Class-I)   - 30 - 34.9 kg/m2 
 Obesity (Class-II)   - 35 - 39.9 kg/m2 
 Morbid Obesity (Class-III)  - > 40 kg/m2 
No flabbiness in the body. 0 
Flabbiness in one anatomical region. 1 
Flabbiness in more than one anatomical region 
which does not cause distress. 
2 
Flabbiness in all over the body which causes 
distress to the patient. 
3 
Unimpaired voice.     
  
0 
Difficult speech which can be understood easi-
ly. 
1 
Difficult speech which can be understood with 
difficulty. 
2 
Difficult speech which cannot  be understood. 3 
No pain.       0 
Mild pain of bearable nature comes 
occasionally. 
1 
Moderate pain, but no difficulty in moving. 2 
Slight difficulty in moving due to pain. 3 
Much difficulty in moving the bodily parts and 
pain is severe. 
4 
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Body Circumference Measurements:  
 Circumferences of fatty parts (Neck, chest, 
abdomen, mid arm, mid forearm, hip, waist, mid thigh, 
mid calf) were recorded before and after treatment, to 
assess the effect of therapy. 
 
Skin Fold Thickness:  
 The skin fold thickness was measured by Vernier 
calipers before and after treatment in fixed areas of 
middle portions of the biceps and triceps muscles, 
middle portion of the supra iliac region and the anterior 
surface of midthigh region and of abdominal muscle at 
umbilicus. 
 
Treatment protocol: 
Total 15 patients of Sthaulya were treated in the 
Bilvadi Panchmool Ghanvati group. 
Details:  
 
 The research drug was prepared by Govt. 
Ayurvedik Pharmacy at Rajpipala. 
 
Assessment of Overall effect of therapy:- 
The overall effect was decided on the basis of 
Improvement in Subjective parameters and reduction in 
Objective criteria i.e. Weight, BMI, Skin fold thickness 
and W/H Ratio. 
In this part, percentage improvement in 
Objective criteria i.e. Weight, BMI, Skin fold thickness 
and W/H ratio were assessed and then average of all the 
percentage improvement was taken. Similarly for 
subjective parameters percentage improvement in each 
subjective parameter present in the patient was assessed 
and then average of all the percentage improvement of 
subjective parameters was taken.  
For percentage improvement in each Objective 
parameter, it is calculated at maximum or upper normal 
limit of normal range i.e. for BMI, percentage 
improvement is calculated by assuming 25 (upper limit 
of normal range) as 0 and improved percentage derived 
from difference of before and after treatment 
assessment. 
Finally to assess the total effect of the Therapies 
an average of Subjective and objective parameter was 
taken. Thus the total effect of the Therapies was marked 
as following:  
Drug Bilvadi Panchmool Ghanvati 
Dose 4tablets (each 500mg) 3 times a 
Total dose 6 gm per day 
Anupana Madhu Udaka 
Duration 8 Weeks 
Time of Before meal 
 
 
Statistical Estimation of results 
The Wilcoxon signed-rank test is applied to the 
statistical data for evaluating the Subjective Criteria. 
Chi square test is applied to the statistical data for 
evaluating the difference in the effects of two therapies 
symptom wise. 
Students Paired‘t’ applied to the statistical data 
for evaluating the difference in the    B.T. and A.T. 
scores of Objective parameters. Students Unpaired‘t’ 
test is applied for evaluating the difference in the effects 
of two therapies Objective Parameter wise. 
 
Observations 
In the present study of 17 patients of Sthaulya, 
maximum  number of patients were in the age group of 
31‑45 years (52.94%),females (82.35%), Hindu by 
religion (70.58%), married (76.47%), belonging to 
middle socioeconomic class (64.71%), and from  
Sadharana Desha.(100%). Further, in this study 
maximum number of patients were of Kapha Vata 
Prakriti (41.17%), Tamsik Prakriti (47.06%). 58.82% 
patients of this study were vegetarian, 58.82 % patients 
were doing only the routine work,41.17% patients were 
having sedentary life, 76.47% patients were having 
sound sleep and 41.18% were jolly in nature. 
 Majority of the patients in this study, that is, 
82.35% were consuming Snigdha Guna followed by 
64.70% Guru Guna Pradhana diet and 76.47% willing 
to Madhura Rasa, followed by 70.58% Lavana Rasa. 
Bhojanottara Jalapana was observed in 82.35%, 
64.70% were taking regular diet, Tikshnagni in 47.05%, 
Madhyama Koshtha in 70.59%. 
In this study, as chief complains, Maximum i.e. 
100 % of the patients were found to have chief 
complaints of Chala Udara followed by 82.35 % 
reporting Chala Sphika, 82.35 % reporting Chala Stana 
and Ati Kshdha,  88.23 % reporting Alasya /Utsahahani, 
76.47 % reporting Ayasena Shwasa /Kshudra Shwasa, 
76.47 % reporting Nidradhikya  and Swedadhikya, 
76.47 % reporting Ati Pipasa, 82.35 % reporting 
Percentage of 
Relief 
Effects 
100% Complete remission 
75-99% Markedly improved 
50% - 75% Moderately improved 
25% – 50% Improved 
10% - 25% Mildly improved 
0% – 10% Unchanged 
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Daurbalya, 58.82 %  reporting Daurgandhya. 
In objective criteria, maximum 52.94% of 
patients were having weight in the category of 70-80 
kg. Maximum 41.18% of the patients were having BMI 
in the range of 30-34.90 kg/m2 (Grade 1 obesity). 
Maximum i.e. 33.33% of the male patients were having 
waist circumference more than 102 cm and 78.57% 
females were having waist circumference more than 88 
cm. Maximum i.e. 100% of the male patients were 
having waist to hip ratio more than 0.9 and 71.43% 
females were having waist to hip ratio more than 0.85. 
As biochemical investigation, maximum 58.82% 
patients were having S. Cholesterol   < 200 mg/dl. 
 
Table: 1 Subjective criteria: chief complaints 
 
 
Table 2: objective criteria: 
BMI Found In 17  Patients of Sthaulya (Obesity) 
 
 
Waist Circumference Found In  3 Males of Sthaulya 
(Obesity) 
 
Chief complaints Number of % 
Chala Sphika 14 82.35 
Chala Udara 17 100 
Chala Stana 14 82.35 
Alasya /Utsahahani 15 88.23 
Ayasena Shwasa /
Kshudrashwasa 
13 76.47 
Daurblyata-Alpa 
Vyayam 
14 82.35 
Nidradhikya 13 76.47 
Swedadhikya 13 76.47 
Daurgandhya 10 58.82 
Ati Pipasa 13 76.47 
Ati Kshudha 14 82.35 
Alpa Vyavaya 7 41.18 
Anga Shaithilya 9 52.94 
Gadgadvani 1 5.88 
BMI (kg/m2) No. of Patients % 
25 - 29.9 6 35.29 
30 – 34.9 7 41.18 
35 – 40 4 23.53 
Waist 
circumference 
(in cm) 
No. of 
Patients 
% 
≤102 2 66.67 
>102 1 33.33 
Waist Circumference Found In 14 Females of 
Sthaulya (Obesity) 
 
  
Waist To Hip Ratio Observed In 3 Male of Sthaulya 
(Obesity) 
 
 
Waist To Hip Ratio Observed In 14 Female of 
Sthaulya (Obesity) 
 
 
Effect of Bilvadi Panchmool Ghanvati 
Subjective criteria:  
 Improvement in symptoms were Alasya/ Utsahahani 
(laziness or lack of enthusiasm) 45.45%, Kshudra 
Shwasa (dyspnoea on exertion) by 63.64% and 
Daurblyata-Alpa Vyayam (weakness) 48.28% which 
were highly significant. 
 Improvement in symptoms like Chala Sphika 
(Visible Movement In Hip) 20.51%, Chala Udara 
(Visible Movement In Abdomen) 26.19%, Chala 
Stana(Visible Movement In Breast) 19.35%, 
Nidradhikya (excess sleep) 47.83%, Swedadhikya 
(excess sweating) 44.83%, Daurgaandhya (body 
odour) by 42.11 %, Ati Pipasa (excess thirst) 52% 
and Ati Kshudha (excess hunger) 45% which were 
significant. 
 Improvements in symptoms like Alpa Vyavaya (Less 
Libido) 31.25%, Anga Shaithilya (flabbiness in the 
body) 33.33% and Gadgadvani (Indistinct speech) 
0.00% which were no significant. 
 
 
 
 
 
Waist 
circumference 
(In cm) 
No. of Patients % 
> 88 11 78.57 
≤ 88 3 21.43 
Waist 
circumference 
No. of 
Patients 
% 
>0.9 3 100 
≤ 0.9 0 00 
Waist 
circumference 
No. of Patients % 
>0.85 10 71.43 
≤ 0.85 4 28.57 
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Table 3: Effect of Therapy on subjective criteria 
 
 
Objective criteria:   
 There was a highly significant decrease of 2.87% and 2.85% found in Weight and BMI respectively. 
 There was a highly significant decrease in organ measurement of 2.83% and 1.48% was found in Waist and Chest 
respectively. 
 There was a statistically significant reduction in organ measurement was reported in Hip by 1.59% and 1.39% in 
Mid arm, while Abdomen, Mid thigh, Mid calf also reduced significantly by 1.74%, 1.59% and 1.04% respectively. 
 Insignificant reduction of 1.04% and 1.30% were found in Neck and Mid forearm respectively. 
 There was a significant decrease in W/H Ratio of 1.52%. 
 There was a significant decrease in various skin fold thickness i.e. Biceps by 6.33%, Triceps 7.07%, Abdomen 
6.57%, Supra iliac 10.79%.  
 
Table 4: Effect of Therapy on Weight and BMI of Patients of Sthaulya (Obesity) 
 
 ↑-Increase, ↓- Decrease 
 
Table 5: Effect of Therapy on Body Organ Measurement of Patients of Sthaulya (Obesity) 
 
 ↑-Increase, ↓- Decrease 
W/H RATIO: There was a decrease in W/H Ratio of 1.52%, which was statistically significant (p<0.05). 
Symptoms Mean 
B.T. 
Mean 
A.T 
Mean 
Diff. 
% 
Change 
‘W’ ‘N’ ‘P’ 
 Chala Sphika 3 2.38 0.62 20.51↓ 36.00 13 <0.01 
Chala Udara 2.8 2.07 0.73 26.19↓ 55.00 15 <0.01 
Chala Stana 2.58 2.08 0.5 19.35↓ 21.00 12 <0.05 
Alasya/Utsahahani 2.54 1.38 1.16 45.45↓ 91.00 13 <0.001 
Kshudra Shwasa 2.75 1 1.75 63.64↓ 78.00 12 <0.001 
Daurbalyata-Alpa 
Vyayama 
2.42 1.25 1.17 48.28↓ 78.00 6 <0.001 
Nidradhikya 2.09 1.09 1 47.83↓ 45.00 11 <0.01 
Swedadhikya 2.42 1.33 1.09 44.83↓ 55.00 12 <0.01 
Daurgaandhya 1.9 1.1 0.8 42.11↓ 36.00 10 <0.01 
Atipipasa 2.08 1 1.08 52↓ 55.00 12 <0.01 
Atikshudha 1.67 0.92 0.75 45↓ 36.00 12 <0.01 
Alpa Vyavaya 2.28 1.57 0.71 31.25↓ 15.00 7 >0.05 
Anga Shaithilya 1.88 1.25 0.63 33.33↓ 15.00 8 >0.05 
Gadgadvani 1 1 0 0 0.00 1 >0.05 
Sandhi Shoola 2.8 1.4 1.4 50↓ 15 5 >0.05 
Parameter 
(n=15) 
Mean Mean 
Differ-
ence 
% 
change 
S.D.± S.E.± ‘t ’ P 
B.T. A.T. 
Weight(kg) 78.07 75.83 2.24 2.87↓ 0.77 0.20 11.34 <0.001 
BMI(kg/m2) 32.08 31.17 0.91 2.85↓ 0.32 0.08 11.12 <0.001 
Parameter 
(n=15) 
(in cm) 
Mean Mean 
Differ-
ence 
% 
change 
S.D.± S.E.± ‘t ’ P 
B.T. A.T. 
Neck 35.78 35.4 0.38 1.04↓ 0.726 0.187 1.81 >0.05 
Mid Arm 33.6 33.13 0.47 1.39↓ 0.481 0.124 3.76 <0.01 
Mid Forearm 25.63 25.3 0.33 1.30↓ 0.772 0.199 1.67 >0.05 
Chest 101.57 100.07 1.5 1.48↓ 1.32 0.34 4.39 <0.001 
Abdomen 99.7 97.97 1.73 1.74↓ 2.74 0.709 2.44 <0.05 
Waist 99.03 99.23 2.8 2.83↓ 1.771 0.457 6.12 <0.001 
Hip 113.33 111.53 1.8 1.59↓ 1.88 0.487 3.69 <0.01 
Mid thigh 56.77 55.87 0.9 1.59↓ 1.478 0.382 2.35 <0.05 
Mid Calf 38.47 38.07 0.4 1.04↓ 0.604 0.156 2.56 <0.05 
W/H Ratio 0.876 0.863 0.013 1.52↓ 0.019 0.004 2.69 <0.05 
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Table 6: Effect of Therapy on Skin Fold Thickness of Patients of Sthaulya (Obesity) 
 
  ↑-Increase, ↓- Decrease, *n=15 
 
Laboratory values:  
There was a decrease of 7.46%, 2.52% and 1.63% found in WBC Total, S.Cholesterol and FBS respectively, 
while there was an increase by 1.45% and 0.93% were found in RBC and Hb (%) respectively. All these changes 
were statistically insignificant. 
 
Overall effect of Therapy: 
 In Bilvadi Panchmool Ghanvati group total 15 patients completed the treatment of which maximum i.e. 6 
patients (40%) reported improved followed by 3 patients (20%) found in each moderately and mild improved. 
(6.67%) was markedly improved while 2 patients (13.33%) remained unchanged. 
 
Table 7: overall effect of therapy 
 
 
Chart: 1          Chart: 2 
  
 
Chart 3: 
 
 
Skin Fold Thick-
ness(in mm) 
BT 
Mean 
AT 
Mean 
Mean 
Diff. 
% 
change 
  
S.D.± 
  
S.E.± 
  
‘t ’ 
  
P 
Biceps 16.44 15.4 1.04 6.33↓ 1.17 0.30 3.45 <0.01 
Triceps 18.09 16.81 1.28 7.07↓ 1.36 0.35 3.64 <0.01 
Abdomen 24.06 22.48 1.58 6.57↓ 1.50 0.39 4.08 <0.01 
Supra iliac 26.20 23.38 2.82 10.79↓ 2.94 0.76 3.73 <0.01 
Improvement No. of Patients % 
Complete remission 0 0 
Markedly improved 1 6.67 
Moderately improved 3 20 
Improved 6 40 
Mildly improved 3 20 
Unchanged 2 13.33 
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Discussion 
 Aacharya Charaka said that as wholesome diet is 
needed for maintenance of body so is the sleep. Obesity 
and leanness are particularly caused by sleep and diet 
(6). Therefore we discuss causative factors as: 
 
Aharaj Nidana (Dietary Factors) 
 In Aharaja Nidanas, Madhura Ahara Sevana was 
found in Maximum i.e. 81.82% patients followed by 
Guru Ahara Sevana in 76.47%, Atisnigdha Ahara and 
Navanna in 70.59 % in each, Atibhojanat in 58.82 % 
Dadhi Sevana in 41.17%.  
 
Viharaja Nidana 
 In Viharaja Nidanas, Maximum i.e. 76.47% 
patients were found to have Avyayama (lack of 
excersice) as a Nidana followed by 58.82% of the 
patients having Divaswapa. 
 
Mansika Nidana (Psychological factors) 
 Among psychological factors Nityapraharsh 
(always jolly nature) was found predominant in 64.71% 
followed by Achintana (thinking less) in 47.06% 
patients and Atichinta (stress) in 35.29 % patients. 
Mansika nidana may act in two ways, mental tendency 
like Nityaharsha and Achintana leads to mental 
satisfaction and Sthairya, which may to increase Manda, 
Stimita, Sandra and Guru Guna of Kapha. While 
Atichintana and chintita (stress and anxiety) helps to 
diminish the function of Rasa Vaha Srotas (7) and also 
decreases normal digestive power(8) which ultimately 
decreases Jatharagni and Medodhatvagni, which causes 
Ajirna hence leading to Ama formation thus 
deteriorating the pathogenesis further 
 
Other factors 
 Beejadosha (positive parental history) was 
reported in 35.29% of patients.  
 
Mode of action of Bilvadi Panchmool Ghanvati 
In the disease Sthaulya, Tikshnagni occurs. Here, 
Jatharagni is found in excessive condition whereas 
Medodhatvagni is found in Manda condition. It is due to 
Avarana of Vayu in Kostha. So person indulges in more 
food, which produce excessive Meda and this vitiated 
cycle go on. This cycle is wrecked (Samprapti 
Vighatana) by Kashaya - Tikta Rasa and Ushna-Virya 
Pradhana drugs. 
All the five drugs of Bilvadi Panchmool Ghanvati 
possess Kashaya and Tikta Rasa as Pradhana Rasa. 
Kashaya Rasa has Samshamana, Shoshana, Shelshma 
Rakta Pitta Prashamana, Kledashoshana, Ruksha, 
Sheeta and Laghu.(9)Tikta Rasa by its Laghu (light), 
Ruksha (dry) properties; helps in Kaphashamana.(10) 
Brihat Panchamoola is having Ushna Virya 
which helps to pacify Vriddha Vata. It is having 
Madhura Rasa as Anurasa which alleviates Pitta. 
 
Adverse Drug Reaction 
No any adverse drug reaction or side effects 
were observed during or after completion of treatment. 
So the treatment which is employed in the study is safe. 
 
Conclusion 
By the assessment of subjective and objective 
criteria, significant difference was found in before and 
after treatment. As a whole, it can be concluded that 
Bilvadi Panchmool Ghanvati has shown very good 
effect in the patients, which is also proved statistically. 
Bilvadi Panchmool Ghanvati showed result by its 
virtues of Vata-Kaphanashana and Deepana which also 
justifies Kapha-Vata dominancy of Sthaulya. The fact 
substantiate hypothesis that use of Vata-Kaphanashana 
drug is as useful as the drug prepared with Guggulu in 
Sthaulya. 
Bilvadi Panchmool Ghanvati has significant 
effect in Sthaulya. 
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